Eterna Therapeutics | 8-K: Current report
Mar 22 16:34 ET
Eterna Therapeutics | 10-K/A: Annual report (Amendment)
Mar 18 07:34 ET
Eterna Therapeutics | 10-K: Annual report
Mar 14 16:41 ET
Eterna Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cicala Peter
Feb 16 17:33 ET
Eterna Therapeutics | 8-K: Current report
Feb 16 07:31 ET
Eterna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John D. Halpern(9.99%),Katherine H. Halpern(9.99%)
Jan 31 07:06 ET
Eterna Therapeutics | 424B3: Prospectus
Jan 24 16:20 ET
Eterna Therapeutics | EFFECT: Others
Jan 23 00:00 ET
Eterna Therapeutics | 8-K: Current report
Jan 19 00:00 ET
Eterna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nicholas Jason Singer(9.99%),Purchase Capital LLC(9.99%)
Jan 19 00:00 ET
Eterna Therapeutics | CORRESP: CORRESP
Jan 18 22:40 ET
Eterna Therapeutics | UPLOAD: Others
Jan 17 22:44 ET
Eterna Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jan 16 00:00 ET
Eterna Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Jan 12 00:00 ET
Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luther Sanjeev
Jan 3 00:00 ET
Eterna Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Luther Sanjeev
Jan 3 00:00 ET
Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clarke Dorothy J
Jan 3 00:00 ET
Eterna Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Charles Cherington(19.99%)
Dec 22, 2023 12:05 ET
Eterna Therapeutics | 8-K: Current report
Dec 20, 2023 16:20 ET
Eterna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-IAF, LLC(9.99%)
Dec 20, 2023 15:24 ET
No Data
No Data